Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

被引：0
|
作者：
Gary T. Ferguson
Patrick Darken
Shaila Ballal
Mohd Kashif Siddiqui
Barinder Singh
Sumeet Attri
Ulf Holmgren
Enrico de Nigris
机构：
[1] Pulmonary Research Institute of Southeast Michigan,
[2] AstraZeneca,undefined
[3] Parexel International,undefined
[4] AstraZeneca,undefined
[5] AstraZeneca,undefined
来源：
Advances in Therapy | 2020年 / 37卷
关键词：
Chronic obstructive pulmonary disease; Exacerbations; Inhaled corticosteroid; Long-acting muscarinic antagonist; Long-acting β; -agonist; Lung function; Network meta-analysis; Patient-reported outcomes; Triple therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2956 / 2975
页数：19
相关论文
共 42 条
  • [1] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
    Ferguson, Gary T.
    Darken, Patrick
    Ballal, Shaila
    Siddiqui, Mohd Kashif
    Singh, Barinder
    Attri, Sumeet
    Holmgren, Ulf
    de Nigris, Enrico
    ADVANCES IN THERAPY, 2020, 37 (06) : 2956 - 2975
  • [2] A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
    Sion K.Y.J.
    Huisman E.L.
    Punekar Y.S.
    Naya I.
    Ismaila A.S.
    Pulmonary Therapy, 2017, 3 (2) : 297 - 316
  • [3] Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combinations in COPD
    Siddiqui, Mohd Kashif
    Shukla, Pragya
    Jenkins, Martin
    Ouwens, Mario
    Guranlioglu, Deniz
    Darken, Patrick
    Biswas, Mousumi
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [4] Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combinations Compare to Long-Acting β-Agonist/Inhaled Corticosteroid Combinations: A Network Meta-Analysis
    Ahmed, T. Said
    Al-Sarie, M.
    Srour, K.
    Rygielski, S.
    Ye, F.
    Hernandez, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for COPD: A systematic review and meta-analysis
    Horita, Nobuyuki
    Miyazawa, Naoki
    Tomaru, Koji
    Inoue, Miyo
    Kaneko, Takeshi
    RESPIROLOGY, 2015, 20 (08) : 1153 - 1159
  • [6] Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
    Oba, Yuji
    Chandran, Arul V.
    Devasahayam, Joe V.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (06) : 677 - 685
  • [7] Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
    Oba, Yuji
    Sarva, Siva T.
    Dias, Sofia
    THORAX, 2016, 71 (01) : 15 - 25
  • [8] Lifetime Benefits for Budesonide/Glycopyrrolate/Formoterol Fumarate versus Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist and Inhaled Corticosteroid/Long-Acting β2-Agonist Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease
    De Nigris, E.
    Treharne, C.
    Brighton, N.
    Holmgren, U.
    Walker, A.
    Haughney, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)
    Horita, Nobuyuki
    Goto, Atsushi
    Shibata, Yuji
    Ota, Erika
    Nakashima, Kentaro
    Nagai, Kenjiro
    Kaneko, Takeshi
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (02):
  • [10] Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β2-agonist) in asthma patients: a narrative review
    Wechsler, Michael E.
    Oppenheimer, John J.
    JOURNAL OF ASTHMA, 2023, 60 (09) : 1633 - 1645
12345